Bramsgaard Bioenergi ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2016
2016/10
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  17.7% 12.9% 4.3% 4.8% 4.8%  
Credit score (0-100)  11 20 49 46 45  
Credit rating  B BB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2016
2016/10
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Net sales  0 0 0 0 0  
Gross profit  0.0 -48.0 -5.4 -5.4 -5.4  
EBITDA  0.0 -48.0 -5.4 -5.4 -5.4  
EBIT  0.0 -48.0 -5.4 -5.4 -5.4  
Pre-tax profit (PTP)  0.0 -48.0 -4.4 -0.9 -1.4  
Net earnings  0.0 -44.1 -3.4 -0.7 -1.1  
Pre-tax profit without non-rec. items  0.0 -48.0 -4.4 -0.9 -1.4  

 
See the entire income statement

Balance sheet (kDKK) 
2016
2016/10
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Tangible assets total  0.0 77.6 77.6 128 128  
Shareholders equity total  400 356 352 352 351  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 363 357 356 355  

Net Debt  0.0 -279 -23.2 -14.9 -12.3  
 
See the entire balance sheet

Volume 
2016
2016/10
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -48.0 -5.4 -5.4 -5.4  
Gross profit growth  0.0% 0.0% 88.7% 0.0% 0.0%  
Employees  0 0 0 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 363 357 356 355  
Balance sheet change%  0.0% 0.0% -1.6% -0.2% -0.3%  
Added value  0.0 -48.0 -5.4 -5.4 -5.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 78 0 50 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2016
2016/10
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -13.2% -1.2% -0.3% -0.4%  
ROI %  0.0% -13.5% -1.2% -0.3% -0.4%  
ROE %  0.0% -5.8% -1.0% -0.2% -0.3%  

Solidity 
2016
2016/10
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Equity ratio %  100.0% 98.1% 98.7% 98.7% 98.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 581.7% 428.6% 274.5% 227.5%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2016
2016/10
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Quick Ratio  0.0 40.8 62.1 6.3 6.1  
Current Ratio  0.0 40.8 62.1 6.3 6.1  
Cash and cash equivalent  0.0 279.5 23.2 14.9 12.3  

Capital use efficiency 
2016
2016/10
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 278.3 274.9 24.0 23.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2016
2016/10
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 -5 -5  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 -5 -5  
EBIT / employee  0 0 0 -5 -5  
Net earnings / employee  0 0 0 -1 -1